Streetbeat News

Regulatory

MCD

McDonald's is under scrutiny as the USDA investigates whether beef is the source of an illness outbreak. The trace back process is ongoing, and McDonald's spokespeople are cooperating with the USDA's efforts.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2024 | 4:25 pm

MCD

McDonald's is investigating a potential link between its beef products and a recent outbreak. The company has not ruled out beef as a contributing factor.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2024 | 4:25 pm

COF

DFS

The New York Attorney General, Letitia James, is seeking court permission to issue antitrust subpoenas related to Capital One's deal with Discover. This investigation could have implications for both companies involved.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2024 | 4:15 pm

MCD

McDonald's is addressing an E. Coli outbreak linked to slivered onions in its Quarter Pounders. The company has temporarily removed the product from restaurants in 13 states and is collaborating with the CDC and suppliers to ensure food safety and restore supply.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2024 | 4:11 pm

SPY

Federal Reserve's Thomas Barkin did not address the economy or monetary policy in his recent speech on community colleges. This lack of commentary leaves markets without new insights into potential Fed actions.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2024 | 4:01 pm

MCD

McDonald's shares are under pressure due to an E. coli outbreak linked to its hamburgers, resulting in multiple analyst downgrades and a 4.24% drop in stock price.

Portfolio Pulse from Adam Eckert

October 23, 2024 | 3:59 pm

GSK

PFE

The FDA has approved Pfizer's RSV vaccine, Abrysvo, for adults aged 18-59 at high risk, expanding its previous indication for those 60 and older. This approval is based on the Phase 3 MONeT study. Pfizer aims to publish these results and present them at a conference. Despite the approval, sales of RSV vaccines from Pfizer and GSK have declined due to regulatory changes. Pfizer's stock is slightly down.

Portfolio Pulse from Vandana Singh

October 23, 2024 | 3:31 pm

FTNT

Fortinet has disclosed a critical vulnerability in its FortiManager API, identified as CVE-2024-47575, which has been exploited in zero-day attacks. The flaw allows attackers to steal sensitive files, including configurations and credentials. Fortinet warned customers privately before the news leaked online.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2024 | 3:09 pm

AAPL

GS

The CFPB has ordered Apple and Goldman Sachs to pay over $89 million for mishandling Apple Card transaction disputes and misleading consumers about interest-free payment options. The companies failed to properly manage disputes and misled customers about interest-free plans, resulting in penalties and restrictions.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2024 | 2:12 pm

CNSP

CNS Pharmaceuticals (CNSP) stock surged 86% after receiving a Nasdaq notice for failing to meet the $1.00 minimum bid price requirement. The company is ineligible for a 180-day extension due to past reverse stock splits and has requested a hearing on November 5 to delay delisting.

Portfolio Pulse from Henry Khederian

October 23, 2024 | 2:08 pm